Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)

NCT00325546 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
643
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi